# Multispan

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/multispan

- Industry: Biotechnology
- Headquarters: Hayward, US
- Website: www.multispaninc.com
- Total disclosed funding: $0.6M
- Latest round: Series B (Dec 21, 2007)
- Investors on record: 1

## About

Multispan, Inc. is a specialized biotechnology firm focusing on cell-based assay services for drug discovery, particularly emphasizing G protein-coupled receptors (GPCRs), providing innovative solutions to pharmaceutical and biotech industries.Founded by Helena Mancebo, Multispan, Inc. operates from Hayward, US, and specializes in developing and providing high-throughput screening (HTS) solutions. The company raised USD 0.6 mn in a Series B funding round from Amkey Ventures on December 21, 2007, with a current valuation of USD 10.765 mn. Multispan has engaged in one major deal since its inception.Multispan, Inc. specializes in cell-based assay services and products targeting the drug discovery market, with a strong focus on G protein-coupled receptors (GPCRs). Their proprietary MULTISCREEN™ platform encompasses cell engineering, assay development, and high-throughput screening (HTS) to provide personalized solutions. They offer a variety of services including custom cell-based assay development, drug discovery services, and secondary compound profiling, catering to pharmaceutical and biotech clients primarily in North America and Europe to support multiple drug development stages.Multispan, Inc. generates revenue through a diverse portfolio of B2B assay services and products. Their clients access a catalog of well-characterized cell lines and assay kits, often resulting in contracts for specific projects or ongoing collaborations. Revenue streams include direct sales of MULTISCREEN™ assay kits, custom cell line development, and GLP-1 receptor profiling services, promoting sustained relationships and recurrent business engagements with clients.In response to their latest funding round on December 21, 2007, where Amkey Ventures invested USD 0.6 mn in Series B financing, Multispan, Inc. plans to enhance its product offerings and expand into new geographic markets. Upcoming product launches are set to introduce advanced assay solutions, with a focus on meeting the evolving needs of drug discovery. The company aims to enter additional markets in Europe and Asia by 2025, utilizing recent funding to strengthen its R&D capabilities and operational infrastructure.

## Funding rounds

- Series B, Dec 21, 2007, $0.6M — Amkey Ventures

## Investors

- Amkey Ventures (https://capitalatlas.ai/funds/amkey-ventures) — Series B